Portland, OR -- (SBWIRE) -- 07/19/2017 -- Illegal drug is non-prescribed type of drug taken for non-medicinal reasons that affects physical and mental health of addicts. According to National Survey on Drug Use and Health, 19.9 million Americans use illegal drugs in a month. There were more than 208 million people consuming illegal drugs worldwide. Change in life style attracts younger people to consume illicit drugs, which is a major driver for the drug abuse testing market. There are 253,000 death occurred due to consumption of illicit drugs out of which 1.3% are of the age between 15-35 years in US. Increase in variety of drug consumption ceases the flexibility of drug testing devices. Increase in drug variety creates complexities in identifying drug level in drug testing devices, this stands as a major restraints for the market.

"Early Buyers Will Receive 20% Customization on This Report."

Get PDF Brochure @ https://www.alliedmarketresearch.com/request-toc-and-sample/112

Governments are taking initiatives to help drug addicts. For example, US government has recently funded more than 60 inpatient and outpatient drug treatment centers across the country. The US government also opened a center in support with UNODC's to develop protocol for treating opiate addicted children. According to UN, there is a need for $250 billion every year to treat drug abuse victims. This shows the potential for drug abuse testing market. This report gives intelligence about the application of drug testing in various types of illicit drugs, competitive landscape of key companies involved in drug testing devices, and market estimation based on current and future growth.

Key players in drug abuse industry include Biomedical Diagnostics, BioMerieux, Abbott Laboratories, Bio-Rad, Dako, DiaSorin, Eiken and Fujirebio, Beckman Coulter.